Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Effector Therapeutics
Biotech
MBX Biosciences, MaaT Pharma and more—Chutes & Ladders
Metabolic disorder biotech lands industry vet as CMO. MaaT welcomes ex-Autolus leader. Former Seagen execs take Shape.
Gabrielle Masson
,
Andrea Park
Jun 28, 2024 8:30am
The end of eFFECTOR Therapeutics: Oncology biotech winds down
Jun 24, 2024 10:19am
Moderna promotes Andres to new strategy role—Chutes & Ladders
Sep 30, 2022 9:30am
J&J's Mammen abruptly leaves top R&D job—Chutes & Ladders
Aug 12, 2022 9:30am
Aum bags $27M to hit cancer targets pursued by Bayer, Roche
Oct 13, 2021 8:40am
EFFECTOR binds to SPAC Locust Walk to move clinical trials along
May 27, 2021 10:50am